Dubai Police seize AED115.2m in narcotics, putting controlled-medicine checks back on pharmacy agendas

Dubai Police arrested 14 people and seized 2.323 tonnes of narcotic pills and psychotropic substances worth AED115,191,233, according to a Khaleej Times report published on 2 October 2026.

The immediate audience is pharmacy COOs, medical directors and insurer fraud teams. The police case concerns illicit supply, but the named substances include medicines that UAE providers also handle through controlled prescription channels, including Tramadol, Xanax and Lyrica. That makes the case relevant for licensed clinics, hospital pharmacies, community pharmacies and payers managing controlled-medicine claims in Dubai, Abu Dhabi and the northern emirates.

What Dubai Police said was seized

Khaleej Times reported that the drugs were packed in 113 cartons and linked to an organised crime network outside the UAE. The seized items included narcotic pills, psychotropic substances, Mydriacyl eye drops, crystal meth, marijuana and papers containing narcotic substances.

For operators, the list matters because the UAE’s legal system draws a hard line between licensed prescribing and illicit possession or distribution. The UAE Government portal states that narcotic, psychotropic and other controlled medicines in class A or B are restricted and cannot be freely imported into the country. It also points to Ministry of Health and Prevention approvals for import of narcotic drugs.

The relevant health regulators are Dubai Health Authority (DHA) for Dubai, Department of Health Abu Dhabi (DOH) for Abu Dhabi and Al Ain, and Ministry of Health and Prevention (MOHAP) for the northern emirates. The federal framework also includes the Emirates Drug Establishment, which DHA cites for approved medication classifications.

Why clinics and pharmacies should care

DHA says its Drug Control section governs processes for medications according to classifications approved by the Emirates Drug Establishment, including approvals for custody transfer of controlled, semi-controlled and narcotic medications to healthcare professionals by approved specialty. That is an operating control, not a public-relations issue.

• Dubai pharmacies should check that controlled and semi-controlled drug custody approvals, registers and dispensing workflows match DHA requirements.
• Abu Dhabi pharmacies should check DOH rules for medication delivery, including the requirement that an original or electronic prescription is presented before dispensing controlled or semi-controlled medicines.
• Northern emirates providers should check MOHAP requirements for controlled-medicine handling, traveller import approvals and pharmacy records.
• Medical directors should review prescribing privileges by specialty for medicines with addiction or habituation risk.

The financial exposure is specific. UAE legislation published on the federal legislation portal says a pharmacy violation can carry imprisonment of at least five years and a fine of at least AED50,000 where the violation facilitates narcotic drug use. It also increases penalties for physicians who issue prescriptions for narcotic or psychotropic substances without a licence, without medical justification or outside approved limits.

Insurers have a narrower task. Daman, Thiqa and Sukoon should treat controlled-medicine claims as a fraud, waste and abuse checkpoint when benefit rules permit reimbursement. The useful tests are dated prescription validity, prescriber licence, diagnosis link, repeat-dispense rules and pharmacy licence status. A rejected claim can become a patient-access issue if the rejection logic cannot distinguish misuse risk from a lawful chronic-care prescription.

What patients need to check

Patients should use licensed providers and keep documentation current. For travellers, the UAE Government portal says electronic approval is available for personal import of narcotic and psychotropic controlled medications, with quantities limited to the patient’s need for up to three months. Residents should check the relevant regulator and insurer before travelling with controlled medicines or requesting refills near a prescription expiry date.

There is no reliable public price range for every controlled medicine named in the police case. Patients should get medicine prices from a licensed pharmacy and then verify reimbursement through their insurer’s app, call centre or pharmacy benefit desk. For controlled medicines, the lowest price is less relevant than legal supply, prescriber eligibility and stock availability.

The next operator question is audit readiness. A pharmacy manager should be able to produce, within the internal deadline set by compliance, the prescription, prescriber licence details, Emirates ID or patient identifier, dispensing record, stock movement record and any regulator approval tied to a controlled or semi-controlled medicine. If those records sit across separate systems, the risk is operational before it is legal.

For licensed pharmacy options, readers can use the UAE Open Healthcare Directory to identify regulated pharmacy providers before sending patients to a dispenser or building a payer network.